Announcements Trials
Browse Landscape

Phase

Phase 2 5

Status

Unknown 5Completed 1

Sponsor Class

NIH 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Breast Neoplasms 24Colorectal Neoplasms 19Rectal Neoplasms 11Stomach Neoplasms 9Colonic Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Carcinoma, Hepatocellular 7Neoplasm Metastasis 6Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Liver Neoplasms 5Esophageal Neoplasms 5Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4Osteosarcoma 4Cholangiocarcinoma 4Peritoneal Neoplasms 3Ovarian Neoplasms 3Neuroblastoma 3Multiple Myeloma 3Lung Neoplasms 3Locally Advanced Rectal Cancer 3Kidney Neoplasms 3Inflammatory Breast Neoplasms 3Turcot syndrome 2Sarcoma 2Pancreatic Neoplasms 2Nasopharyngeal Carcinoma 2Head and Neck Neoplasms 2Glioblastoma 2

Interventions

Sorafenib 9Radiofrequency Ablation 7Oxaliplatin 7Fluorouracil 6Doxorubicin 6Neoadjuvant Therapy 5toripalimab 4lenvatinib 4Injections 4Chemotherapy, Adjuvant 4Bevacizumab 4sintilimab 3pembrolizumab 3Ultrasonography 3Thalidomide 3Leucovorin 3Irinotecan 3Cisplatin 3tislelizumab 2durvalumab 2camrelizumab 2anlotinib 2Walking Speed 2Standard of Care 2Radiosurgery 2Oncolytic Virotherapy 2Metformin 2Liver Transplantation 2Laparoscopy 2Immunohistochemistry 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Liver Neoplasms × Neoadjuvant Therapy × Clear all
NCT00077389 2014-06-24

Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma

National Cancer Institute (NCI)

Phase 2 Unknown
57 enrolled
Gastrointestinal

Liver Neoplasms, Hepatoblastoma

NCT00276705 2013-09-17

Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
47 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00659022 2011-09-12

Neo-adjuvant Therapy and the Effect on Synchronous Metastatic Growth

Radboud University Medical Center

Phase 2 Unknown
60 enrolled
Gastrointestinal

Liver Neoplasms, Colorectal Neoplasms

NCT00471484 2011-06-22

Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Unknown
54 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01182272 2010-08-16

Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Unknown
36 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡